Global Space Ventures invests in the $15M seed round of Colossal, a breakthrough bioscience and genetic engineering company focused on leveraging CRISPR technology for extinct species restoration, critically endangered species protection, ecosystems restoration, and advancing and building the future of genetic engineering, and synthetic biology.
“In 2014, I asked my friend Elon Musk who he knew who was poised to make profound changes in the field of genomics, and he said: George Church.
So in June 2014, I visited George at his lab in Boston. I immediately knew I’d be looking for an opportunity to collaborate with George. Global Space Ventures is excited to be backing Colossal. George Church’s personal passion for the mission, combined with the stellar team assembled by serial entrepreneur Ben Lamm, is at the perfect intersection of audacious yet achievable. The path to de-extinction is now at hand, and leveraging CRISPR/Cas9 technology, to bring back extinct species and preserve those that we have, will have profound importance to humanity.”
Laetitia Garriott de Cayeux
Founder/CEO of Global Space Ventures
Learn more here.
To follow along, visit: www.colossal.com
Global Space Ventures 